Sign in

CIK 0001600620

  • Large accelerated filer

Aurinia Pharmaceuticals Inc.

Sign in to watch
Ticker
AUPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981231763
Phone
+1 250-744-2487
Business address
#140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$735,889
in 3 filings

Net −$735,889. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Robertson Stephen P. −$736K Chief Legal Officer sold 7% of stake
Date Insider Transaction Shares Price Value Owned after
2022-05-18 Balakrishnan Brinda Director Grant or award · Restricted Stock Unit +8,733 8,733
2022-05-18 Balakrishnan Brinda Director Grant or award · Stock Option (right to buy) +14,612 14,612
2022-05-18 Hagan Joseph P Director Grant or award · Restricted Stock Unit +8,733 8,733
2022-05-18 Hagan Joseph P Director Grant or award · Stock Option (right to buy) +14,612 14,612
2022-03-09 MacKay-Dunn R. Hector Director Purchase +5,000 $11.00 $55K 11,000
2022-03-04 MILNE GEORGE M JR Director Purchase +5,000 $10.82 $54K 50,000
2022-03-02 Martin Michael Robert Chief Business Officer Grant or award +8,500 64,361
2022-03-02 Martin Michael Robert Chief Business Officer Sale −4,849 $12.01 $58K 59,512
2022-03-02 Martin Michael Robert Chief Business Officer Grant or award · Restricted Stock Unit +62,448 62,448
2022-03-02 Martin Michael Robert Chief Business Officer Grant or award · Stock Option (right to buy) +106,838 106,838
2022-03-02 Donley Matthew Maxwell Ex VP, Intern'l Operations Grant or award +8,500 19,276
2022-03-02 Donley Matthew Maxwell Ex VP, Intern'l Operations Sale −3,052 $12.01 $37K 16,224
2022-03-02 Donley Matthew Maxwell Ex VP, Intern'l Operations Grant or award · Restricted Stock Unit +104,080 104,080
2022-03-02 Donley Matthew Maxwell Ex VP, Intern'l Operations Grant or award · Stock Option (right to buy) +178,063 178,063
2022-03-02 Miller Joseph M Chief Financial Officer Grant or award +8,500 9,670
2022-03-02 Miller Joseph M Chief Financial Officer Sale −3,060 $12.01 $37K 6,610
2022-03-02 Miller Joseph M Chief Financial Officer Grant or award · Restricted Stock Unit +104,080 104,080
2022-03-02 Miller Joseph M Chief Financial Officer Grant or award · Stock Option (right to buy) +178,063 178,063
2022-03-02 Colao Massimilano Chief Commercial Officer Grant or award +8,500 16,700
2022-03-02 Colao Massimilano Chief Commercial Officer Sale −3,205 $12.01 $38K 13,495

Page 11 of 18 · 345 trades